¶ … Tuberculosis vaccine has been around for decades. However, tuberculosis is still one of the most significant reasons for death globally. Furthermore amidst the still developing nations, tuberculosis has not decreased, with cases on the rise annually. Measures to prevent tuberculosis must be taken. Recent studies and articles relaying information on better medications, and increased efforts towards prevention has led to potential decline in tuberculosis cases. Within the next decade, hopes are for Africa, where tuberculosis diagnosis remains high, to also see a decline. Notwithstanding these developments, full scale-up of tuberculosis and HIV cooperative undertakings remains perplexing and evolving drug-resistant tuberculosis is slowly becoming a key threat.
Morbidity and Mortality Statistics
This article review will focus on existing information on tuberculosis cases to better understand the spread of tuberculosis globally. It will contain articles that examine the failure of national programs to address treatment and diagnosis of tuberculosis which adds to the annual death rates of TB. Along with an evolving drug-resistant strain of tuberculosis, the latest research focuses on new vaccines and treatments to counteract the evolving disease. There needs to be a visible improvement in diagnostics when it comes to TB therefore some articles will also be presented discussing new diagnostic tests and screenings. "In 2008, an estimated 440,000 cases of MDR tuberculosis emerged globally....
In an article by Zumla (2013) author discusses new and original drugs and treatments for all forms of TB such as Bedaquiline. Bedaquiline is approved by the FDA, however is not recommended for all TB patients as it does have serious adverse reactions. While on the medication, they may experience headache, chest pain, and nausea. Ever since the 1960's there hasn't been much change in way of treatments and vaccinations. However this article highlights emerging ones. Such programs that involve testing TB medications and getting them FDA approved are likely to employ both repurposed drugs and new biological mechanism. More than a few of these treatments are now succeeding through clinical trials. Zumla covers present ideas and modern developments in TB drug innovation and growth, including an update of continual TB regimen trials, newer clinical trial proposals, TB biomarkers and aide-de-camp host-directed therapies (Zumla, 2013, pp. 388).
Not only does the article highlight…
Tuberculosis’ policies, finance, global prevention, and treatment initiatives related to Tuberculosis by their applicable ethics principles. Considerable headway has been achieved in the battle against tuberculosis in the 21st century – a total of forty-nine million patients’ lives have been saved. But the disease continues to pose a major health threat, especially to highly vulnerable population groups worldwide (Organization, W 2009). Tuberculosis prevention, diagnosis, care and treatment gives rise to both
Tuberculosis in Newham Borough of London The Urban Health Profile It is true that as long as there have been human beings on planet earth there has been a certain amount of struggle against disease and creatures that carry disease along with bacteria and viruses. These are the types of struggles and successes which have determined whether or not civilizations would triumph or be defeated, and these are the struggles which will
Tuberculosis Communicable disease: Tuberculosis Tuberculosis is a widespread, lethal, and infectious/transmittable disease caused by Mycobacterium tuberculosis. This bacterial infection usually begins in the form of innumerable strains of mycobacteria. In the past, tuberculosis was also termed as Phthisis or Phthisis pulmonalis. Its short form is known worldwide to be TB, or MTB. Stereotypically, tuberculosis is a lung infection that attacks the lungs; however, it can as well affect the other parts of
Others are more reckless and assume that they simply will not get sick. No matter who they are or where they come from, though, anyone can contract TB if they get around someone who is infected, so people must put social, cultural, and other opinions aside in order to protect themselves and others around them from potentially deadly diseases like TB (Lawlor, 2007). Conclusion It is very easy to see that
5 per 100,000 in 1986. In 1994, the number of TB cases among residents of correctional facilities for 59 reporting areas had reached 24,361 (4.6% of the total reporting correctional population) (Braithwaite et al.). The incidence rate was 139.3 per 100,000 by 1993 and the unadjusted case rates for prison populations in many areas are significantly higher than the rates for the general population (Braithwaite et al.). According to these
Tuberculosis and AIDS Quarantines -- Ineffective Strategies of Disease Control Imagine this. You sit next to someone in a crowded subway car, or come into contact with someone on a daily basis because they live in the same apartment complex. That person coughs frequently, and sometimes spits up blood. Later you find out that person had a contagious disease -- tuberculosis. Then you start to cough. You go to your doctor